Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$11,382,427
+$491,403 QoQ
Shares Held
44,818
+0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#1,032
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $60,692,879 across 13 Drug Manufacturers - General names. JNJ ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,310 | $20,762,135 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
44,818 | $11,382,427 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,037 | $6,943,754 | |
| 4 | ABBV |
AbbVie Inc.
|
20,828 | $5,241,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
30,439 | $3,845,663 | |
| 6 | PFE |
Pfizer Inc
|
157,717 | $3,797,825 | |
| 7 | AMGN |
Amgen Inc
|
9,769 | $3,537,550 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
40,142 | $2,312,982 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,382,427 | 44,818 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $10,891,024 | 44,555 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,296,400 | 44,921 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $8,915,549 | 48,083 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $8,056,646 | 52,744 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $8,951,711 | 53,978 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,570,857 | 52,350 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,640,390 | 53,316 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,849,230 | 53,703 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $8,893,441 | 56,220 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,292,957 | 59,289 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $9,918,315 | 63,681 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,529,058 | 63,612 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $9,948,055 | 64,181 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $22,243,061 | 125,916 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $10,244,632 | 62,712 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,784,346 | 43,853 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,706,464 | 60,410 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,490,867 | 61,325 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $9,662,545 | 59,830 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,531,197 | 57,856 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,461,629 | 57,570 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,795,181 | 55,885 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,646,179 | 51,358 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,985,654 | 49,674 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,484,640 | 49,452 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||